Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 828 of 5804
-
New hope for HER2 cancers: targeted drug shows promise in Mid-Stage trial
Disease control OngoingThe purpose of this study is to find out what effects, a drug called ado-trastuzumab emtansine has on the patient and their cancer which is thought to be controlled by the abnormal HER2 gene.
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Could a pill combo replace chemo for some breast cancers?
Disease control OngoingThe purpose of this study is to determine if ribociclib in combination with letrozole for 24 weeks as neoadjuvant endocrine therapy increases the proportion of women with Pre-operative Endocrine Prognostic Index (PEPI) score of 0 at surgery compared to patients treated with letro…
Phase: PHASE2 • Sponsor: Qamar Khan • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Liver transplant breakthrough: new Clot-Busting technique saves grafts
Disease control CompletedBackground: To evaluate the safety and efficacy of intraoperative endovascular treatment (EVT) using the donor ligamentum teres hepatis (LTH) approach for Yerdel grade III/IV portal vein thrombosis (PVT) during liver transplantation (LT), a condition that poses a major challenge …
Sponsor: Chiyi Chen • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Lung bath chemo during surgery aims to wipe out hidden sarcoma cells
Disease control Recruiting nowSarcoma which has spread to the lungs is most often treated with surgery. Even with surgery, most patients will not be cured and will die from their disease, probably because of small cancer cells that are present in the lungs at the time of surgery, but cannot be seen or detecte…
Phase: PHASE1 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Promising combo therapy for infant leukemia enters human trials
Disease control OngoingThe purpose of this study is to test the good and bad effects of the study drugs bortezomib and vorinostat when they are given in combination with chemotherapy commonly used to treat acute lymphoblastic leukemia (ALL) in infants. For example, adding these drugs could decrease the…
Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Surgery may tame seizures in brain tumor patients
Disease control Recruiting nowBackground: Some people with brain tumors have seizures related to the tumor. This is called tumor-related epilepsy. Usually brain tumors are treated by removing as much of the brain tumor as possible without causing problems. Researchers think this may improve the outcome for p…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Radiation plus two immunotherapy drugs shows promise in advanced cancers
Disease control CompletedThe main purpose of this study is to determine how best to combine hypofractionated radiotherapy, MEDI4736, and tremelimumab and to determine how safe and tolerable hypofractionated radiotherapy, MEDI4736, and tremelimumab are when given together in subjects with metastatic, mela…
Phase: PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Vaccine-Chemo combo shows promise against spread prostate cancer
Disease control CompletedBackground: Metastatic castrate-sensitive prostate cancer is cancer that has spread beyond the prostate area. It can be controlled by lowering the amount of testosterone in the body. This is called androgen deprivation therapy (ADT). The vaccine PROSTVAC might help the immune sy…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Can a Drug-Vaccine combo delay leukemia in High-Risk patients?
Disease control CompletedThis randomized phase II trial studies how well ibrutinib works when given together with vaccine therapies in treating patients without clinical signs or indications that raise the possibility of a particular disorder or dysfunction (asymptomatic) who have high-risk chronic lymph…
Phase: PHASE2 • Sponsor: Jennifer Woyach • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Swallow a sponge to spot cancer early?
Diagnosis Recruiting nowThis study is to identify potential biomarkers for the early detection of Barrett's Esophagus, esophageal carcinoma (both adenocarcinoma and squamous cell carcinoma), and gastric cancer via sponge cytology.
Sponsor: Johns Hopkins University • Aim: Diagnosis
Last updated Jun 27, 2026 08:04 UTC
-
New drug may free MDS patients from frequent blood transfusions
Disease control OngoingThe purpose of this study is to evaluate the efficacy and safety of imetelstat sodium in transfusion-dependent participants with low or intermediate-1 risk myelodysplastic syndrome (MDS) that is relapsed/refractory to erythropoiesis-stimulating agent (ESA) treatment in Phase 2 st…
Phase: PHASE2, PHASE3 • Sponsor: Geron Corporation • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New drug duo shows promise in tough lung cancer
Disease control CompletedThe purpose of the study is to define the safety and tolerability of this drug combination. The study will also define the response rate of patients with advanced and unresectable NSCLC.
Phase: PHASE1, PHASE2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New hope for NF1 patients: drug shows promise against inoperable tumors
Disease control OngoingBackground: Neurofibromatosis type 1 (NF1) is a disorder that can cause plexiform neurofibromas (PNs). These are tumors that grow along nerves. Some PNs cause serious health problems. PNs often can t be operated on because of their large size, location, or number. There are no e…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New drug combo shows promise for rare genetic cancers
Disease control OngoingThis phase II MATCH treatment trial identifies the effects of trametinib and dabrafenib in patients whose cancer has genetic changes called BRAF V600 mutations. Dabrafenib may stop the growth of cancer by blocking BRAF proteins which may be needed for cell growth. Trametinib may …
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New 'Bottom-Up' surgery for rectal cancer could mean faster recovery
Disease control CompletedStandard surgical treatment of mid and low rectal cancer is total mesorectal excision (TME). Originally performed by open surgery, TME demonstrated improved local control and reduced urogenital morbidity. Laparoscopic approach has been validated by several randomised controlled t…
Phase: PHASE3 • Sponsor: Institut Paoli-Calmettes • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Immune booster added to standard cancer care shows promise in early trial
Disease control OngoingThe purpose of this research study is to test the safety and the benefit of adding pembrolizumab (a therapy that activates the immune system to fight cancer) to standard of care treatment for head and neck cancer. The standard of care treatment will include surgery followed by ra…
Phase: PHASE2 • Sponsor: Trisha Wise-Draper • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
AI boosts cataract surgery precision for severely nearsighted patients
Diagnosis Recruiting nowThis study aims to establish a multi-center artificial intelligence model for the accurate calculation of intraocular lens and its clinical application in highly myopic cataract, so as to improve the accuracy of the prediction of postoperative diopter in highly myopic cataract pa…
Sponsor: Shanghai High Myopia Study Group • Aim: Diagnosis
Last updated Jun 27, 2026 12:32 UTC
-
Gene therapy shows promise for rare eye disease causing blindness
Disease control CompletedThe goal of this clinical trial is to assess the effectiveness of GS010, a gene therapy, in improving the visual outcome in participants with Leber Hereditary Optic Neuropathy (LHON) due to the G11778A ND4 mitochondrial mutation when vision loss is present for more than six month…
Phase: PHASE3 • Sponsor: GenSight Biologics • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Could stem cells restore sight in damaged eyes?
Disease control Recruiting nowThis study will evaluate the use of autologous bone marrow derived stem cells (BMSC) for the treatment of retinal and optic nerve damage or disease.
Phase: NA • Sponsor: MD Stem Cells • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New chemo cocktail aims to boost survival in kids with rare lymphoma
Disease control OngoingThe outcomes of children with lymphoblastic lymphoma (LBL) in China in the investigators' previous study were not unexpected. In this study, through further modification treatment protocols and strengthen domestic multicenter collaboration, the investigators try to improve surviv…
Phase: PHASE3 • Sponsor: Children's Cancer Group, China • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC